Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MC3R | P41968 | 9/20 | 0.43 |
| ▸ | MC4R | P32245 | 8/20 | 0.43 |
| ▸ | MC1R | Q01726 | 1/20 | 0.43 |
| ▸ | MC5R | P33032 | 8/20 | 0.37 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | F2 | P00734 | 3/20 | 0.35 |
| ▸ | PLG | P00747 | 2/20 | 0.35 |
| ▸ | PLAT | P00750 | 2/20 | 0.35 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.35 |
| ▸ | F10 | P00742 | 1/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10085169 | 0.96 | MC3R (0.43) | MC3RMC4RMC1RMC5RACHE | |
| SCHEMBL12387488 | 0.96 | MC3R (0.43) | MC3RMC4RMC1RMC5RACHE | |
| SCHEMBL13045406 | 0.94 | MC3R (0.49) | MC3RMC4RMC1RMC5RACHE | |
| SCHEMBL12387566 | 0.93 | MC3R (0.43) | MC3RMC4RMC1RMC5RACHE | |
| SCHEMBL12387461 | 0.93 | MC3R (0.43) | MC3RMC4RMC1RMC5RACHE | |
| SCHEMBL14524599 | 0.92 | MC3R (0.43) | MC3RMC4RMC1RMC5RACHE | |
| SCHEMBL16299312 | 0.91 | MC3R (0.42) | MC3RMC4RMC1RMC5RACHE | |
| SCHEMBL16299303 | 0.90 | MC3R (0.41) | MC3RMC4RMC1RMC5ROPRM1 | |
| SCHEMBL12387583 | 0.90 | MC3R (0.49) | MC3RMC4RMC1RMC5RACHE | |
| SCHEMBL21376572 | 0.90 | MC3R (0.49) | MC3RMC4RMC1RMC5RACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7834144-B2 | Prion-specific peptoid reagents | NOVARTIS AG (CH) | 2010-11-16 | — | — | US | disclosed |